Financial reports
10-K
2023 FY
Annual report
21 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2022 FY
Annual report
16 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
28 Jul 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
15 Feb 22
10-Q
2021 Q3
Quarterly report
3 Nov 21
Current reports
8-K
Other Events
15 Apr 24
8-K
Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
15 Feb 24
8-K
Ultragenyx Reports Preliminary 2023 Revenue; Guidance for 2024 Revenue and Cash Usage; Pipeline Updates and 2024 Milestones
8 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
21 Dec 23
8-K
Ultragenyx Reports Third Quarter 2023 Financial Results and Corporate Update
2 Nov 23
8-K
Entry into a Material Definitive Agreement
23 Oct 23
8-K
Results of Operations and Financial Condition
16 Oct 23
8-K
Departure of Directors or Certain Officers
8 Sep 23
8-K
Ultragenyx Reports Second Quarter 2023 Financial Results and Corporate Update
3 Aug 23
8-K
Ultragenyx Appoints Howard Horn as Chief Financial Officer and Executive Vice President, Corporate Strategy
12 Jul 23
Registration and prospectus
S-3ASR
Automatic shelf registration
21 Feb 24
424B5
Prospectus supplement for primary offering
20 Oct 23
FWP
Free writing prospectus
18 Oct 23
424B5
Prospectus supplement for primary offering
17 Oct 23
S-8
Registration of securities for employees
8 Jun 23
S-8
Registration of securities for employees
16 Feb 23
S-8
Registration of securities for employees
15 Feb 22
424B5
Prospectus supplement for primary offering
7 May 21
S-3ASR
Automatic shelf registration
12 Feb 21
S-8
Registration of securities for employees
12 Feb 21
Proxies
DEFA14A
Additional proxy soliciting materials
24 Apr 23
DEF 14A
Definitive proxy
24 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
DEFA14A
Additional proxy soliciting materials
22 Apr 19
DEF 14A
Definitive proxy
22 Apr 19
Other
SEC STAFF
SEC staff action: Order
2 Dec 19
SEC STAFF
SEC staff action: Order
6 Nov 19
CT ORDER
Confidential treatment order
30 Aug 18
CT ORDER
Confidential treatment order
20 Apr 18
CT ORDER
Confidential treatment order
13 Jan 17
CT ORDER
Confidential treatment order
9 Jan 17
CT ORDER
Confidential treatment order
22 Dec 15
EFFECT
Notice of effectiveness
8 Jul 14
CT ORDER
Confidential treatment order
3 Feb 14
EFFECT
Notice of effectiveness
30 Jan 14
Ownership
4
Eric Crombez
19 Apr 24
4
Theodore Alan Huizenga
18 Apr 24
4
Thomas Richard Kassberg
12 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
4
Matthew K Fust
11 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
4
Howard Horn
5 Mar 24
4
Karah Herdman Parschauer
5 Mar 24
4
Thomas Richard Kassberg
5 Mar 24
4
Dennis Karl Huang
5 Mar 24